CLEOPATRA trial
E261834
UNEXPLORED
The CLEOPATRA trial was a pivotal phase III clinical study that demonstrated improved survival by adding pertuzumab (Perjeta) to trastuzumab and docetaxel in patients with HER2-positive metastatic breast cancer.
Referenced by (1)
| Subject (surface form when different) | Predicate |
|---|---|
|
Perjeta
→
|
clinicalTrial |